Defunct Company
Total Trials
6
As Lead Sponsor
As Collaborator
0
Total Enrollment
317
NCT01838551
Treatment for Endogenous Cushing's Syndrome
Phase: Phase 3
Role: Lead Sponsor
Start: Aug 31, 2014
Completion: Nov 30, 2018
NCT03277690
A Study to Assess the Safety and Efficacy of Levoketoconazole in the Treatment of Endogenous Cushing's Syndrome.
Start: Sep 26, 2017
Completion: Aug 31, 2020
NCT03768388
Levoketoconazole Food Effect Study in Healthy Subjects
Phase: Phase 1
Start: Nov 30, 2018
Completion: Dec 24, 2018
NCT03621280
Open-label Treatment in Cushing's Syndrome
Start: Jan 7, 2019
Completion: Dec 31, 2022
NCT03880825
Drug Interaction Study of Levoketoconazole and Metformin
Start: Mar 28, 2019
Completion: May 3, 2019
NCT04212000
Bioavailability of Levoketoconazole and Ketoconazole Tablets
Start: Dec 16, 2019
Completion: Jan 23, 2020